{"id":"W4315650998","doi":"10.1016/j.lungcan.2023.01.006","title":"Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; Prevention of Organ Failure","funders":"Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Ipilimumab; Pembrolizumab; Internal medicine; Oncology; Population; Lung cancer; Hazard ratio; Atezolizumab; Docetaxel; Cancer; Confidence interval; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006992984,0.0009943541,0.01143253,0.0003579539,0.0001968687,0.00006142533,0.0002769402,0.0003537143,0.0001892767],"category_scores_gemma":[0.00004203142,0.0006465807,0.002249623,0.002406717,0.0001294385,0.0001095994,0.0001043704,0.0004493776,0.000001379974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006599808,"about_ca_system_score_gemma":0.0004436859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001389599,"about_ca_topic_score_gemma":0.001393969,"domain_scores_codex":[0.9959074,0.0003464223,0.00182933,0.001043111,0.0003542787,0.000519451],"domain_scores_gemma":[0.9958568,0.001132853,0.001580382,0.0008412773,0.0003954099,0.0001932916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001189915,0.00004955525,0.00004681748,0.756201,0.232654,0.000008014299,0.002129771,0.0001529009,0.000001529845,0.000008653949,0.0008305613,0.006727269],"study_design_scores_gemma":[0.003339662,0.000267534,0.00008804291,0.4014127,0.5648035,0.00001120053,0.00002912982,0.0001672017,0.000001643674,0.000001578749,0.02926313,0.0006146551],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000458289,0.979459,0.0007732292,0.0003940401,0.0002159275,0.01772302,0.00129214,0.00005272959,0.00004400685],"genre_scores_gemma":[0.00007023825,0.9857399,0.0003903802,0.000578719,0.0002108605,0.007619482,0.0002065552,0.0001440414,0.005039864],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3547884,"threshold_uncertainty_score":0.9995986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07048827422576923,"score_gpt":0.3953027253379456,"score_spread":0.3248144511121764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}